Top 10 AI Startups in Healthcare for 2024

Instant diagnoses and targeted treatments - the reality AI is bringing to healthcare. Over the past decade, AI startups have become healthcare's superheroes, wielding cutting-edge tech to tackle critical issues.

The AI revolution in healthcare is transforming patient care, streamlining operations, and achieving top-notch clinical outcomes. With early disease detection and personalized treatment plans, AI startups are leading the charge towards a healthier future for all.

The AI in Healthcare market is currently booming - Markets and Markets research report shows it will hit a cool $20.9 billion in 2024, and it's projected to explode to $148.4 billion by 2029.

10 Best AI Startups in Healthcare for 2024

1. Verily

Verily Life Sciences LLC, (formerly Google Life Sciences) a 2015 Alphabet Inc. subsidiary headquartered in South San Francisco, California, spearheads the development of cutting-edge wearables, robust data analysis platforms, and population health tools. Their mission is to unlock the power of health data for a healthier world. They tackle complex healthcare challenges, from chronic disease management to strategic population health initiatives, through their innovative solutions.

Verily is known for its next-level wearables, like smart contact lenses that monitor your health in real-time. Powerful analytics platforms that crack the codes of complex health issues and keep chronic conditions in check to crafting strategies for healthier communities, Verily's innovations have brought the power of personalized healthcare at our fingertips.

2. Modernizing Medicine

Daniel Cane, the CEO of Modernizing Medicine, founded the company in 2010 in Boca Raton, Florida. The company has raised over $332 million and specializes in healthcare IT solutions, including electronic health records (EHR), practice management, and data services, all tailored to specialty medical practices. Their systems are designed to improve efficiency and outcomes in medical practices by using data to drive clinical decisions and streamline operations, ultimately enhancing patient care quality.

Modernizing Medicine uses data to empower physicians with actionable insights that improve patient outcomes. By analyzing extensive clinical data, their systems provide predictive analytics that help physicians make more informed decisions. For instance, their analytics can suggest customized treatment plans based on historical outcomes data for similar patient profiles, thereby enhancing the precision and effectiveness of patient care.

3. Komodo Health

Arif Nathoo, the CEO of Komodo Health, founded the company in 2014 and is based in San Francisco, California. With funding exceeding $314 million, the company’s primary objective is to minimize the global disease burden by leveraging AI to analyze vast amounts of data, producing actionable insights that enable healthcare providers to design effective treatment plans and interventions. Komodo Health’s platform aims to enhance the efficiency of healthcare delivery through detailed patient journey insights that help in understanding and intervening in disease progression.

Komodo Health's platform is designed not just to collect data but to transform it into actionable insights that healthcare providers can use to craft more effective and personalized treatment plans. These insights also facilitate proactive interventions, potentially preventing disease progression before it becomes more serious. By mapping patient journeys in granular detail, Komodo Health helps medical professionals and healthcare systems understand complex patterns of disease progression and patient interaction with healthcare systems.

4. Spring Health

April Koh and Adam Chekroud co-founded Spring Health, which is located in New York. CEO April Koh oversees the company, which has attracted over $300 million in funding. Spring Health provides personalized mental health care solutions to employers, using AI to guide treatment and improve mental health outcomes efficiently. The important approach of Spring Health’s is its use of sophisticated artificial intelligence technology to guide treatment options.

By utilizing AI, Spring Health can analyze individual employee data to predict the most effective treatment paths and recommend personalized interventions. This method significantly improves the accuracy and speed of finding the right care for each employee, which is often a complex and time-consuming process in traditional mental health care systems.

5. Tempus

Eric Lefkofsky founded Tempus in 2015, and its headquarters are in Chicago, Illinois. With over $1 billion in funding, Tempus uses AI to analyze clinical and molecular data to personalize cancer treatment. The company supports physicians with real-time data-driven decisions and operates one of the largest libraries of clinical and molecular data.

Moreover, the integration of clinical data with molecular and genomic insights enables a multidimensional view of a patient's condition, providing a more holistic approach to cancer treatment. This data synergy is crucial for advancing oncology research, leading to faster development of new treatments, and improving the outcomes of clinical trials by identifying the best candidates for specific drug therapies.

6. Human Longevity

Human Longevity Inc. is headquartered in San Diego, California, and was established in 2013. The company is currently under the leadership of interim CEO David Karow and has attracted over $300 million in funding. Human Longevity Inc. is at the forefront of integrating genomics and artificial intelligence to enhance healthcare by offering comprehensive health assessments that aim to extend the healthy lifespan of individuals.

The core mission of Human Longevity Inc. is to revolutionize preventative healthcare by harnessing the power of genome sequencing and advanced diagnostic tools. These technologies enable the company to provide deep insights into an individual’s health risks and potential genetic predispositions. By analyzing a person's genomic data, Human Longevity Inc. can identify markers linked to various diseases long before symptoms appear, facilitating early intervention strategies.

7. Biofourmis

CEO Kuldeep Singh Rajput founded Biofourmis, which opened its doors in 2015 and has its headquarters in Boston, Massachusetts. The company has successfully secured over $145 million in funding, underscoring its role as a pioneer in the field of AI-driven personalized healthcare. Biofourmis specializes in leveraging advanced analytics and artificial intelligence to enhance remote patient monitoring.

The primary focus of Biofourmis is to revolutionize patient care by developing sophisticated software that harnesses the power of data collected from wearable devices. This data is crucial as it provides real-time insights into a patient's physiological parameters. By employing AI and machine learning algorithms, Biofourmis' technology analyzes this data to predict potential health issues before they become critical, thus enabling preemptive medical intervention.

8. PathAI

PathAI, founded in 2016 by Andy Beck and Aditya Khosla, is situated in Boston, Massachusetts. Under the leadership of CEO Andy Beck, the company has garnered significant financial backing, securing over $255 million in funding. PathAI is dedicated to enhancing the field of pathology through the development of artificial intelligence tools that aid pathologists in diagnosing diseases with greater accuracy and efficiency.

The company's innovative AI-driven technology is designed to transform the traditional processes of pathology. By integrating AI with pathological analysis, PathAI's tools help pathologists identify and interpret disease indicators more quickly and with higher precision than conventional methods allow. This technology significantly reduces human error and increases the reliability of diagnoses, which are critical for determining the most effective treatment plans for patients.

9. DarioHealth

Erez Raphael, the CEO of DarioHealth, founded the company in 2011, and it is based in New York. The company has successfully raised over $50 million in funding, marking its place as a significant player in the mobile health solutions sector. DarioHealth is primarily focused on the development of digital platforms that manage chronic diseases effectively.

DarioHealth's innovative approach centers around leveraging real-time data gathered through mobile devices to empower individuals with chronic conditions to manage their health more proactively. The company's technology enables users to monitor their health metrics continuously, facilitating immediate and informed decisions regarding their lifestyle and treatment options. This real-time monitoring is particularly crucial for conditions like diabetes, where constant vigilance over blood sugar levels can prevent severe complications.

10. K Health

CEO Allon Bloch is the driving force behind K Health, which began operations in 2016 and has its headquarters in New York City. The company has impressively raised over $271 million in funding, demonstrating strong support and confidence in its innovative approach to healthcare. K Health is dedicated to transforming the healthcare experience by utilizing artificial intelligence to deliver personalized medical advice through its mobile application.

K Health's platform stands out for its ability to provide users with precise health assessments by comparing their symptoms against a comprehensive database of medical information. This database includes anonymized health records from millions of doctor visits, which the AI uses to identify patterns and diagnose with a high level of accuracy. Such a resource is invaluable in helping users understand their symptoms and potential conditions without immediate access to a healthcare provider.

AI startups are at the forefront of a healthcare revolution. Their ability to use cutting-edge technology to address complex medical challenges is not just improving the efficiency and effectiveness of healthcare today but is also setting the stage for a future where healthcare is more proactive, personalized, and accessible to all.